Cholangitis in ulcerative colitis--a risk factor for colonic malignancy?

W Kruis¹

Affiliations

Comment

W Kruis. Int J Colorectal Dis. 2000 Jun.

. 2000 Jun;15(3):172.

doi: 10.1007/s003840000224.

W Kruis¹

No abstract available

Comment on

Liver involvement in patients operated for ulcerative colitis, with special reference to the association of cholangitis with colorectal dysplasia and carcinoma.
Aitola P, Mattila J, Matikainen M. Aitola P, et al. Int J Colorectal Dis. 2000 Jun;15(3):167-71. doi: 10.1007/s003840000223. Int J Colorectal Dis. 2000. PMID: 10954188

Risk of colon cancer in patients with ulcerative colitis is potentiated by the presence of primary sclerosing cholangitis.
Kingham JG. Kingham JG. Hepatology. 1997 Jan;25(1):254. doi: 10.1002/hep.510250149. Hepatology. 1997. PMID: 8985303 No abstract available.
Risk of cancer in ulcerative colitis.
Levin B. Levin B. Gastrointest Endosc. 1999 Mar;49(3 Pt 2):S60-2. doi: 10.1016/s0016-5107(99)70527-4. Gastrointest Endosc. 1999. PMID: 10049450 No abstract available.
Prevention of colon cancer with ursodiol in ulcerative colitis.
Kim HS. Kim HS. Inflamm Bowel Dis. 2001 Aug;7(3):279-80. doi: 10.1097/00054725-200108000-00018. Inflamm Bowel Dis. 2001. PMID: 11515858 No abstract available.
[Colonic carcinoma associated with ulcerative colitis. Risk factors, molecular pathogenesis and surveillance].
Schürmann G, Ochman S, Neurath MF. Schürmann G, et al. Dtsch Med Wochenschr. 2000 Sep 8;125(36):1045-50. doi: 10.1055/s-2000-7211. Dtsch Med Wochenschr. 2000. PMID: 11022601 Review. German. No abstract available.
Definition of primary sclerosing cholangitis.
Farrant JM. Farrant JM. J Hepatobiliary Pancreat Surg. 1999;6(4):329-32. doi: 10.1007/s005340050126. J Hepatobiliary Pancreat Surg. 1999. PMID: 10664277 Review. No abstract available.